News & Updates
Filter by Specialty:
Add-on lenacapavir helps maintain virologic suppression in treatment-naïve PWH
Combining the potent first-in-class capsid assembly inhibitor lenacapavir with other antiretroviral agents led to sustained high rates of virologic suppression in treatment-naïve persons with HIV-1 (PWH) infection, according to the week-54 results of the phase II Calibrate trial.
Add-on lenacapavir helps maintain virologic suppression in treatment-naïve PWH
21 Feb 2022Antibody cocktail may help relieve burden from hospitals
Ronapreve, also known as REGEN-COV, appears to reduce the risk of hospitalization or the need for additional treatment among COVID-19 patients when used in a real-world setting, a study has shown. The therapy is seen as a promising way to minimize the impact of SARS-CoV-2 infection on the public healthcare system.
Antibody cocktail may help relieve burden from hospitals
21 Feb 2022Elevated dietary glycaemic index, load linked to higher CVD mortality risk
Dietary patterns with higher glycaemic index (GI) and glycaemic load (GL) appear to elevate the risk of cardiovascular disease (CVD) mortality, according to a study on Chinese adults.
Elevated dietary glycaemic index, load linked to higher CVD mortality risk
21 Feb 2022Serrated polyposis syndrome patients, relatives at risk of colorectal cancer
The risk of colorectal cancer (CRC) is heightened in patients with serrated polyposis syndrome (SPS) and their first-degree relatives (FDRs), according to a study, which confirms findings of other reports. In addition, those with sessile serrated lesions (SSL) are at higher of prostate cancer.
Serrated polyposis syndrome patients, relatives at risk of colorectal cancer
21 Feb 2022Low free sugar diet benefits obese/overweight patients with NAFLD
Overweight or obese patients with nonalcoholic fatty liver disease (NAFLD) may gain health benefits from a low free sugar diet, results of a trial have shown. Such diet helps reduce hepatic steatosis and fibrosis, as well as improve glycaemic indices and lower concentrations of biomarkers of inflammation, triglycerides (TG), and total cholesterol (TC) levels.
Low free sugar diet benefits obese/overweight patients with NAFLD
21 Feb 2022Starting vedolizumab early better than late for UC
Starting vedolizumab early after the diagnosis of ulcerative colitis (UC) appeared more effective than delaying it to after initiation of other UC treatments, according to the RALEE study.